Artificial Organs Market PPT 2024: Size, Growth, Demand and Forecast till 2032
                     Global Artificial Organs 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
IMARC Group is  a g lobal  management  consul t ing f i rm that  he lps the wor ld ’s  most  ambi t ious 
changemakers  to create a las t ing impact .  Across the s ix  major  cont inents  and 100+ count r ies ,  we 
work a longside our  bus iness par tners  as one team wi th  a common ambi t ion to achieve unparal le led 
resul ts ,  gain a compet i t ive edge,  and t ransform indust r ies .  IMARC Group excels  in  unders tanding 
i ts  c l ients ’  bus iness pr ior i t ies  and del iver ing ta i lored solut ions that  dr ive meaningfu l  outcomes.  Our 
c l ient  base spans over  3,000 organizat ions in  the pr ivate,  publ ic ,  and soc ia l  sectors ,  ranging f rom 
high-growth s tar tups to For tune 500 companies.
We prov ide a comprehensive sui te of  market  entry  and expansion serv ices.  Our of fer ings inc lude 
thorough market  assessment ,  feas ib i l i ty  s tudies,  company incorporat ion ass is tance,  fac tory  setup 
suppor t ,  regulatory  approvals and l icens ing navigat ion,  branding,  market ing and sales st rategies,  
compet i t ive landscape and benchmark ing analyses,  pr ic ing and cost  research,  and procurement  
research.  These serv ices are des igned to ass is t  companies in  evaluat ing market  oppor tuni t ies ,  
set t ing up new ent i t ies ,  navigat ing regulatory landscapes,  boost ing brand v is ib i l i ty ,  analyz ing 
compet i tors,  and opt imiz ing procurement  s t rategies.
Accord ing  to  the  la tes t  repor t  by  IMARC Group,  t i t l ed  "Art i f ic ia l  Organs 
Market :  Global  Industry  Trends,  Share ,  S ize ,  Growth ,  Opportuni ty  and 
Forecast  2024-2032,"  the  g loba l  a r t i f i c ia l  o rgans market  s ize  reached US$ 
20 .6  B i l l i on  in  2023.
Report Art i f i c ia l  o rgans a re  med ica l  dev ices  tha t  a re  eng ineered  and implan ted in to  
the  human body.  The  o rgans  a re  imp lan ted  in  the  body to  rep l ica te  the  
Highlight and natura l  funct ion  o f  a  hea l thy  o rgan .  Ar t i f i c ia l  o rgans are  made f rom p las t i c  seeded wi th  s tem ce l ls  f rom the  t ransp lant  rec ip ient .  
They inc lude  imp lan tab le  dev ices l i ke  fu l l y  ar t i f i c ia l  hear ts  and pacemakers ,  
Description and o rgan suppor t  mach ines  l ike  d ia lys is  and ex t racorporea l  membrane 
oxygenat ion (ECMO) machines .  They do not  need  con t inuous te ther ing  to  
any power  supp ly  and  s ta t ionary  resources to  func t ion.
Request  for  a  PDF sample  of  th is  report :  
ht tps : / /www. imarcgroup.com/ar t i f i c ia l -o rgans-market / reques tsample
Report Description
G l ob a l  Ar t i f i c i a l  O r gans  M ark e t  T rend s :
The  m ar ke t  i s  p r im ar i l y  d r i ven  by  t he  i n c r ea s ing  nu m be r  o f  r oa d  acc i den t s  r esu l t i ng  i n  am pu t a t i ons .  The  r i s i ng  i nc id enc es  
o f  o r gan  f a i lu r es  ca used  d ue  t o  b loo d  l oss ,  d r ug  ab use ,  s e r i ous  t r aum a ,  an d  acu t e  d i sease s  i s  ano t he r  m a jo r  g r ow t h -
i nduc i ng  f ac t o r .  A lon g  w i t h  t h i s ,  r ap i d  l i f es t y l e  d i so r de r s ,  s uch  as  un hea l t hy  d ie t a r y  hab i t s ,  s m ok in g ,  a l coho l  
consu m pt ion ,  and  s eden t a r y  l i f es t y le ,  a r e  a l s o  esc a la t i ng  t he  d em a nd  f o r  a r t i f i c i a l  o r gans .  Bes id es  t h i s ,  t he  sho r t age  o f  
o r gan  do no r s  and  t he  i nc r eas in g  g e r i a t r i c  p opu la t i on  unde r go ing  o r ga n  t r a nsp la n t s  o n  ac coun t  o f  t h e i r  d e t e r i o r a t i n g  
hea l t h  i s  p r ope l l i ng  t he  de m and  f o r  a r t i f i c i a l  o r gan s .  
Nowa days ,  t he  r i s i ng  pub l i c  awar e ness  abou t  adv ancem en t s  i n  m ed ic a l  t ech no log y  and  im pr ovem en t s  i n  t he  hea l t hca r e  
i n f r a s t r uc t u r e  r esu l t i ng  i n  t he  de ve lopm en t  o f  a r t i f i c i a l  suppo r t  sy s t em s .  Fu r t he r m o r e ,  key  m an u f ac t u r e r s  a r e  i n t r o duc in g  
3D  b iop r i n t i ng  and  i n t eg r a t i ng  a r t i f i c i a l  i n t e l l i genc e  ( A I )  i n  a r t i f i c i a l  o r ga ns ,  t hus  c r ea t i ng  a  pos i t i ve  ou t l o ok  f o r  t he  
m ar k e t .
Look i ng  f o rw ard ,  t he  ma rke t  va l u e  i s  ex pec t e d  t o  re ach  US$  4 0 . 6  B i l l i on  b y  203 2 ,  ex h i b i t i ng  a  CAG R o f  7 . 6%  dur i n g  
t he  f o rec as t  per i o d  ( 2 024 - 20 32 ) .
V i ew  Repo r t  T O C,  F i g ures  and  T ab l e s :  h t t ps : / / w w w . i mar cgrou p . com / a r t i f i c i a l - o rgan s- ma rke t
Breakup by Type:
• Artifi cial  Kidney
• Artifi cial  Heart
• Artifi cial  Pancreas
• Cochlear Implants
• Others
Report 
Segmentation Breakup by Region:
• North America
• Europe
• Asia Pacifi c
• Lat in America
• Middle East and Afr ica
• Abiomed, Inc.
• HeartWare International ,  Inc.
• Edwards Lifesciences Corp
Competitive • Boston Scient ifi c Corporation
Landscape • Cochlear Limited
with Key 
Players
What was the size of the global artificial organs 
market in 2023?
What is the expected growth rate of the global 
artificial organs market during 2024-2032?
Key What are the key factors driving the global artificial 
organs market?
Questions 
Answered in What has been the impact of COVID-19 on the global artificial organs market?
the Report
What is the breakup of the global artificial organs 
market based on the type?
What are the key regions in the global artificial 
organs market?
Who are the key players/companies in the global 
artificial organs market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
        2 . 4 . 1     B o t t o m - U p  A p p r o a c h
Table of         2 . 4 . 2     T o p - D o w n  A p p r o a c h    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
    4 . 1     O v e r v i e w
Contents     4 . 2     K e y  I n d u s t r y  T r e n d s5    G l o b a l  A r t i f i c i a l  O r g a n s  M a r k e t    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  B r e a k u p  b y  T y p e
    5 . 5     M a r k e t  B r e a k u p  b y  R e g i o n
    5 . 6     M a r k e t  F o r e c a s t
    5 . 7     S W O T  A n a l y s i s
        5 . 7 . 1     O v e r v i e w
        5 . 7 . 2     S t r e n g t h s
        5 . 7 . 3     W e a k n e s s e s
        5 . 7 . 4     O p p o r t u n i t i e s
        5 . 7 . 5     T h r e a t s
    5 . 8     V a l u e  C h a i n  A n a l y s i s
        5 . 8 . 1     O v e r v i e w
        5 . 8 . 2     R e s e a r c h  a n d  D e v e l o p m e n t
        5 . 8 . 3     R a w  M a t e r i a l  P r o c u r e m e n t
       
        5 . 8 . 4     M a n u f a c t u r i n g
        5 . 8 . 5     M a r k e t i n g
        5 . 8 . 6     D i s t r i b u t i o n
        5 . 8 . 7     E n d - U s e
    5 . 9     P o r t e r s  F i v e  F o r c e s  A n a l y s i s
        5 . 9 . 1     O v e r v i e w
        5 . 9 . 2     B a r g a i n i n g  P o w e r  o f  B u y e r s
        5 . 9 . 3     B a r g a i n i n g  P o w e r  o f  S u p p l i e r s
        5 . 9 . 4     D e g r e e  o f  C o m p e t i t i o n
        5 . 9 . 5     T h r e a t  o f  N e w  E n t r a n t s
        5 . 9 . 6     T h r e a t  o f  S u b s t i t u t e s
6    M a r k e t  B r e a k u p  b y  T y p e
Table of     6 . 1     A r t i f i c i a l  K i d n e y        6 . 1 . 1     M a r k e t  T r e n d s
        6 . 1 . 2     M a r k e t  F o r e c a s t
    6 . 2     A r t i f i c i a l  H e a r t
Contents         6 . 2 . 1     M a r k e t  T r e n d s        6 . 2 . 2     M a r k e t  F o r e c a s t
    6 . 3     A r t i f i c i a l  P a n c r e a s
        6 . 3 . 1     M a r k e t  T r e n d s
        6 . 3 . 2     M a r k e t  F o r e c a s t
    6 . 4     C o c h l e a r  I m p l a n t s
        6 . 4 . 1     M a r k e t  T r e n d s
        6 . 4 . 2     M a r k e t  F o r e c a s t
    6 . 5     O t h e r s
        6 . 5 . 1     M a r k e t  T r e n d s
        6 . 5 . 2     M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  R e g i o n
    7 . 1     N o r t h  A m e r i c a
        7 . 1 . 1     M a r k e t  T r e n d s
        7 . 1 . 2     M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
h t t p s : / / w w w. im a rcg ro u p . co m / a r t i fi c i a l - o rga n s - m a r ke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: